|1.||Kozielski, Frank: 5 articles (03/2013 - 06/2006)|
|2.||Skoufias, Dimitrios A: 3 articles (03/2010 - 06/2006)|
|3.||Saoudi, Yasmina: 2 articles (01/2008 - 06/2006)|
|4.||Good, James A D: 1 article (03/2013)|
|5.||MacKay, Simon P: 1 article (03/2013)|
|6.||Wang, Fang: 1 article (03/2013)|
|7.||Rath, Oliver: 1 article (03/2013)|
|8.||Kaan, Hung Yi Kristal: 1 article (03/2013)|
|9.||Podgórski, Dawid: 1 article (03/2013)|
|10.||Talapatra, Sandeep K: 1 article (03/2013)|
01/01/2008 - "One potent Eg5 inhibitor is S-trityl-L-cysteine (STLC), which arrests cells in mitosis and exhibits tumor growth inhibition activity. "
06/30/2006 - "Human Eg5, responsible for the formation of the bipolar mitotic spindle, has been identified recently as one of the targets of S-trityl-L-cysteine, a potent tumor growth inhibitor in the NCI 60 tumor cell line screen. "
09/15/2011 - "S-Trityl-l-cysteine is an allosteric inhibitor of vertebrate Kinesin Spindle Protein (KSP) that has generated considerable interest due to its anti-cancer properties, however, poor pharmacological properties have limited the use of this compound. "
03/15/2010 - "Mutations in the human kinesin Eg5 that confer resistance to monastrol and S-trityl-L-cysteine in tumor derived cell lines."
|2.||BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
|3.||Prostatic Neoplasms (Prostate Cancer)
|4.||Lung Neoplasms (Lung Cancer)
|1.||Heterologous Transplantation (Xenotransplantation)